Capital Management Inc. Occitan is 10% at Alexza Pharmaceuticals Inc. (ALXA). They have made 1 open-market trade across 1 company since 2012, most recently 2012-01-13.
CIK 0001539739
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $81K since 2012, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXA | 3,678,386 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2012-01-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXA | BUY | 2012-01-10 | 2012-01-20 | $0.82 | $81K | -39.4% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.